Home › Rheumatoid Arthritis › NCT00748254
Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis
RecruitingObservational studyHealthy volunteers welcome
Who can join
Ages 18 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Men and women 18 years of age or older can participate in this study. * Patients can participate in this study if they have had rheumatoid arthritis for more than 2 years and their rheumatologist has referred them to this study. * Patients can participate as a healthy volunteer with a known history of rheumatoid arthritis. Exclusion Criteria: * Patients, who have electrically, magnetically or mechanically activated implants such as heart pacemaker, magnetic surgical clips, prostheses or implanted neurological stimulator. * Pregnant patients. * Patients who is claustrophobic. * Patients with impaired renal function cannot participate in this study such as elevate creatinine clearance, patients on kidney dialysis etc. * Patients with shock hypotension or unstable low blood pressure. * Patients with Rhabdomyolysis. * Patients who have had a contrast enhanced (with gadolinium) MRA (magnetic resonance angiography)/ or MRI within the last 3 months. (Contrast is a medication injected into a vein during a imaging examination that helps produce clearer images/pictures).
About the study
The purpose of this feasibility study is to determine if a new emerging technology called photoacoustic tomography (PAT) can be adapted for use in humans for the detection of chronic rheumatoid arthritis.
What is being tested
- Laser Based Photoacoustic Tomography, MRI, Ultrasound (procedure)
- laser based photoacoustic tomography, MRI, ultrasound (procedure)
Sponsor: University of Michigan · Participants: 113 · Started: Dec 1, 2011
Contact the study team
- Safa Mohamed · Phone: 734 615-1646
Official record on ClinicalTrials.gov — NCT00748254
Locations in the U.S.
| Michigan | Universtity of Michigan Health System, Ann Arbor |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.